OPKO Health, Inc. is a diversified healthcare company focused on improving patient lives through discovery and development of novel technologies, such as the 4Kscore test. The 4Kscore test provides an accurate and personalized measure of men’s risk for aggressive prostate cancer. The four kallikrein panel of biomarkers utilized in the 4Kscore test is based on more than a decade of research conducted by scientists at Memorial Sloan-Kettering Cancer Center and leading European cancer research institutions. 4Kscore is marketed by GenPath, a division of BioReference Laboratories, an OPKO Health Company and the nation’s third largest clinical laboratory. OPKO also offers leading edge genetic testing through GeneDx, our diagnostic laboratory specializing in genetic testing for inherited disorders, including inherited cancers, cardiac, mitochondrial, neurological, prenatal, and other rare disorders.
Brands: OPKO Health, Inc.
BioReference Laboratories, Inc.